Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China flag China · Delayed Price · Currency is CNY
27.14
+0.11 (0.41%)
Apr 30, 2026, 3:00 PM CST

SHA:603351 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,6763,5243,3263,5722,9305,118
Market Cap Growth
5.40%5.95%-6.86%21.88%-42.75%71.80%
Enterprise Value
3,8353,7723,6013,9493,2605,210
Last Close Price
27.1426.0224.2225.6420.8037.17
PE Ratio
24.2323.3422.7231.8330.8450.49
PS Ratio
2.742.642.573.092.644.91
PB Ratio
2.001.961.952.241.983.69
P/TBV Ratio
2.132.092.092.402.113.92
P/FCF Ratio
19.6718.9419.5375.71--
P/OCF Ratio
15.7614.7915.0029.7026.89-
EV/Sales Ratio
2.862.832.783.422.945.00
EV/EBITDA Ratio
11.8712.1313.0519.7218.0532.14
EV/EBIT Ratio
19.9720.1121.2729.8827.8642.55
EV/FCF Ratio
20.5320.2721.1483.72--
Debt / Equity Ratio
0.320.320.280.310.290.14
Debt / EBITDA Ratio
1.831.831.692.392.261.21
Debt / FCF Ratio
3.173.092.8310.32--
Net Debt / Equity Ratio
0.080.080.140.210.220.08
Net Debt / EBITDA Ratio
0.480.490.851.641.800.66
Net Debt / FCF Ratio
0.820.811.376.96-2.60-0.43
Asset Turnover
0.530.540.560.520.560.60
Inventory Turnover
4.834.685.045.025.275.92
Quick Ratio
1.030.980.820.720.480.71
Current Ratio
1.391.301.201.080.811.10
Return on Equity (ROE)
8.37%8.49%8.80%7.10%6.59%7.46%
Return on Assets (ROA)
4.75%4.71%4.54%3.74%3.68%4.40%
Return on Invested Capital (ROIC)
8.41%8.31%7.39%6.37%5.93%7.83%
Return on Capital Employed (ROCE)
9.90%9.90%9.50%7.70%7.50%8.60%
Earnings Yield
4.14%4.28%4.40%3.14%3.24%1.98%
FCF Yield
5.08%5.28%5.12%1.32%-4.26%-4.83%
Dividend Yield
1.48%-1.65%1.17%1.35%0.81%
Payout Ratio
43.16%42.98%37.88%47.61%56.70%44.64%
Buyback Yield / Dilution
0.33%-0.32%-0.29%-1.00%-0.35%-2.25%
Total Shareholder Return
1.83%-0.32%1.36%0.17%1.00%-1.44%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.